Dbs depression
Pro Research Analysisby 
Searched over 200M research papers for "dbs depression"
Deep Brain Stimulation for Treatment-Resistant Depression: A Comprehensive Review
Introduction to Deep Brain Stimulation (DBS) for Depression
Deep brain stimulation (DBS) has emerged as a promising intervention for patients with treatment-resistant depression (TRD), a condition where individuals do not respond to conventional treatments such as pharmacotherapy, psychotherapy, or electroconvulsive therapy (ECT). This article synthesizes findings from multiple studies to evaluate the effectiveness, safety, and optimal parameters of DBS for TRD.
Effectiveness of DBS in Treating TRD
Response and Remission Rates
Several studies have demonstrated significant antidepressant effects of DBS in patients with TRD. A systematic review and meta-analysis reported that DBS targeting the subgenual cingulate cortex (SCC) resulted in a 39.9% response rate and a 26.3% remission rate at 12 months post-treatment1. Another meta-analysis found that DBS significantly reduced depression scores across various brain targets, including the subcallosal cingulate gyrus (SCG), ventral capsule/ventral striatum (VC/VS), medial forebrain bundle (MFB), and nucleus accumbens (NAcc)3. These findings suggest that DBS can be an effective treatment for TRD, with notable improvements in depressive symptoms.
Comparative Efficacy of Different Brain Targets
DBS has been applied to multiple brain regions, each showing varying degrees of effectiveness. For instance, stimulation of the SCG, VC/VS, MFB, and NAcc has been associated with significant reductions in depression scores3. A meta-regression analysis did not find a statistically significant difference between these targets, indicating that multiple regions may be viable for DBS in TRD6. Additionally, a study focusing on the NAcc reported significant reductions in both depression and anxiety symptoms, highlighting its potential as a target for DBS9.
Safety and Adverse Events
DBS is generally considered safe, but it is not without risks. Common adverse events include wound infections, headaches, and hemorrhage, while temporary mood changes, paresthesias, anxiety, and autonomic disturbances can often be managed by adjusting stimulation parameters5. A randomized, sham-controlled trial confirmed the safety of DBS targeting the subcallosal cingulate white matter, although it did not show statistically significant antidepressant efficacy in the short term4. Serious adverse events such as suicide attempts and suicidal ideation have also been reported, underscoring the need for careful patient monitoring10.
Optimization of Stimulation Parameters
The effectiveness of DBS can be influenced by the electrical parameters used. High-frequency stimulation (>100 Hz) is commonly applied, with variations in pulse width and amplitude tailored to individual patient responses8. Three main parameter combinations have been identified: short pulse width with low amplitude, short pulse width with high amplitude, and long pulse width with low amplitude. These combinations have shown varying degrees of efficacy, suggesting that personalized adjustments are crucial for optimizing treatment outcomes8.
Conclusion
DBS offers a promising treatment option for patients with TRD, demonstrating significant reductions in depressive symptoms across various brain targets. While generally safe, the procedure carries risks that necessitate careful patient selection and monitoring. Future research should focus on optimizing stimulation parameters and identifying the most effective neuroanatomical targets to enhance the therapeutic potential of DBS for TRD.
Sources and full results
Most relevant research papers on this topic
Effectiveness and acceptability of deep brain stimulation (DBS) of the subgenual cingulate cortex for treatment-resistant depression: a systematic review and exploratory meta-analysis.
Deep brain stimulation applied to the subgenual cingulate cortex shows potential in reducing short- and medium-term treatment-resistant depression, with maximal effects observed within 6 months.
Meta-Analysis
Rigorous Journal
Highly CitedEfficacy of deep brain stimulation for treatment-resistant obsessive-compulsive disorder: systematic review and meta-analysis
Deep brain stimulation effectively relieves both OCD and comorbid depression symptoms in treatment-resistant obsessive-compulsive disorder patients.
Meta-AnalysisRigorous JournalA systematic review and meta-analysis of deep brain stimulation in treatment-resistant depression
Deep brain stimulation significantly alleviates depressive symptoms in treatment-resistant depression patients, targeting brain regions SCG, VC/VS, MFB, and NAcc.
Meta-AnalysisSubcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial.
Subcallosal cingulate deep brain stimulation is safe and feasible for treatment-resistant depression, but showed no statistically significant antidepressant efficacy in a 6-month double-blind, sham-controlled trial.
RCTRigorous JournalHighly CitedDBS in Treatment-Resistant Depression
DBS shows promise as a new therapeutic method for treatment-resistant depression, with over 50% of patients responding or entering remission in clinical trials.
Literature ReviewDeep Brain Stimulation Is Effective for Treatment-Resistant Depression: A Meta-Analysis and Meta-Regression
Deep brain stimulation (DBS) is effective for treating treatment-resistant depression, with most trials demonstrating its safety and efficacy.
Meta-AnalysisRigorous JournalDeep brain stimulation for treatment-resistant depression: an integrative review of preclinical and clinical findings and translational implications
Deep brain stimulation targeting the SCG, ALIC, and MFB shows more consistent antidepressant response rates in patients with treatment-resistant depression.
Systematic ReviewRigorous JournalHighly CitedDosing of Electrical Parameters in Deep Brain Stimulation (DBS) for Intractable Depression: A Review of Clinical Studies
Three optimal stimulation parameter combinations emerged from a review of DBS studies for treatment resistant depression, with individual variations in response and recovery time.
Systematic ReviewHighly CitedNucleus Accumbens Deep Brain Stimulation Decreases Ratings of Depression and Anxiety in Treatment-Resistant Depression
Deep brain stimulation to the nucleus accumbens effectively reduces depression and anxiety in treatment-resistant depression patients, with potential benefits from increased hedonic activities.
Non-RCTRigorous JournalHighly CitedDeep Brain Stimulation of the Ventral Anterior Limb of the Internal Capsule for Treatment-Resistant Depression: A Randomized Clinical Trial.
Deep brain stimulation of the ventral anterior limb of the internal capsule (vALIC) shows promise in treating treatment-resistant depression, with a significant reduction in HAM-D-17 scores compared to sham stimulation.
RCTHighly Cited